Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2025)
Vycor Medical has reported Cash from Discontinued Operations over the past 7 years, most recently at 308.0 for Q4 2025.
- Quarterly Cash from Discontinued Operations rose 481.13% to 308.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 636.0 through Dec 2025, up 154.4% year-over-year, with the annual reading at 636.0 for FY2025, 154.4% up from the prior year.
- Cash from Discontinued Operations was 308.0 for Q4 2025 at Vycor Medical, up from 53.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 1873.0 in Q2 2021 and troughed at 5483.0 in Q1 2021.
- The 5-year median for Cash from Discontinued Operations is 48.5 (2024), against an average of 199.05.
- Year-over-year, Cash from Discontinued Operations tumbled 287.82% in 2023 and then soared 481.13% in 2025.
- A 5-year view of Cash from Discontinued Operations shows it stood at 189.0 in 2021, then plummeted by 70.37% to 322.0 in 2022, then skyrocketed by 55.59% to 143.0 in 2023, then surged by 137.06% to 53.0 in 2024, then soared by 481.13% to 308.0 in 2025.
- Per Business Quant, the three most recent readings for VYCO's Cash from Discontinued Operations are 308.0 (Q4 2025), 53.0 (Q3 2025), and 226.0 (Q2 2025).